Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.
暂无分享,去创建一个
[1] S. Mandel,et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[2] C. Bal,et al. Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease‐free survival , 2015, Clinical endocrinology.
[3] J. Shah,et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis , 2006, Cancer.
[4] M. Papotti,et al. Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic Approach , 2007, The American journal of surgical pathology.
[5] Sung-Bae Kim,et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. , 2015, The New England journal of medicine.
[6] Mithat Gonen,et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. , 2006, The Journal of clinical endocrinology and metabolism.
[7] R. Tuttle,et al. Update on differentiated thyroid cancer staging. , 2014, Endocrinology and metabolism clinics of North America.
[8] S. Larson,et al. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. , 2013, The Journal of clinical endocrinology and metabolism.
[9] R. Paschke,et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial , 2014, The Lancet.
[10] V. Livolsi,et al. Papillary thyroid carcinoma tall cell variant. , 2008, Thyroid : official journal of the American Thyroid Association.
[11] E. Baudin,et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.
[12] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[13] J. Shah,et al. Outcomes in patients with poorly differentiated thyroid carcinoma. , 2014, The Journal of clinical endocrinology and metabolism.
[14] R. DeLellis. Pathology and genetics of tumours of endocrine organs , 2004 .